ZBH card
ZBH price forecast
Zimmer Biomet$101,41
P/E now is 25,6. Average over 5 years: 47,0 (range 24–65). The stock is 45% below its history.
Base · FY2030
$202,60+18,9% a year
The base case gives 18,9% a year, above your target of 10%.
Settings
%
No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.
Calculated from your assumptions. Not an investment recommendation.
Base · FY2030$202,60+18,9% a year